About
Sarah Skerratt is a medicinal chemist and drug discovery executive currently serving as Chief Research Officer at Isomorphic Labs. She previously served as Chief Scientific Officer at CHARM Therapeutics and held senior scientific leadership roles at MSD, Vertex, Biogen, and Pfizer. Her public profile centers on AI-enabled drug discovery, medicinal chemistry, and advancing therapeutic programs from research into the clinic.
Areas of interest
biotechAI drug discoverymedicinal chemistryoncologyneurosciencediseases of ageingpreclinical researchdrug development